Could this be good news for late stage prostate cancer patients?

New Targeted Therapy Effective In Treating Advanced Prostate Cancer
NEW YORK — An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer (CRPC), known for its poor prognosis and limited treatment options. The research was led by investigators at Memorial Sloan-Kettering Cancer Center…

Based on the positive results of the current study, a multinational randomized Phase 3 clinical trial has begun to examine MDV3100 versus a placebo for the treatment of men with advanced prostate cancer who were previously treated with chemotherapy.

I found this on a weekly cancer info site, Cancer Compass. Go to New Targeted Therapy For Advanced Prostate Cancer to read the entire article–and to get information about openings in this new clinical trial.

Feel good and keep smiling! Pat & Pattie

Leave a Reply